1.Transmitted drug resistance among HIV infected men who have sex with men in Tianjin, 2014-2017.
M N ZHENG ; T L NING ; N ZHOU ; X ZHAO ; L LI ; J J ZHU ; S H CHENG
Chinese Journal of Epidemiology 2018;39(5):619-624
Objective: To understand prevalence and transmission of transmitted drug resistance (TDR) among HIV infected men who have sex with men (MSM) in Tianjin from 2014 to 2017. Methods: A total of 225 blood samples were collected from HIV infected MSM in Tianjin from 2014 to 2017. Pol gene fragments were obtained by viral RNA extraction and nested PCR amplification. Phylogenetic and drug resistance analyses were conducted. Results: A total of 205 samples were successfully sequenced and analyzed. Based on pol sequences, 53.2% (109/205), 28.8% (59/205), 10.2% (21/205), 4.9% (10/205) and 2.9% (6/205) of the samples were positive for HIV subtypes CRF01_AE, CRF07_BC, B, CRF55_01B and unique recombinant forms (URFs). Twenty transmission clusters, including 75 sequences, were identified and 62.5% (10/16) of sequences with TDR were in 5 clusters. The prevalence of TDR was 7.8% between 2014 and 2017. The annual prevalence rate increased from 3.9% (2/51) in 2014, 5.7% (3/53) in 2015, 9.6% (5/52) in 2016 to 12.2%(6/49) in 2017, the difference was not significant (χ(2)=2.504, P=0.127). CRF01_AE and B strains had high TDR prevalence (3.4%, 7/205) and (2.9%, 6/205), respectively. The TDR mutation was mainly NNRTIs, the TDR prevalence was 6.3% (13/205). In contract, the TDR prevalence of NRTIs and PIs were 1.5% (3/205) and 1.0% (2/205) respectively. Conclusion: Results from this study suggested that the prevalence of HIV-1 TDR strains in MSM was serious in Tianjin. It is necessary to take effective prevention and control measures.
China
;
Drug Resistance, Viral/genetics*
;
Genes, pol
;
Genotype
;
HIV Infections/transmission*
;
HIV Reverse Transcriptase/genetics*
;
HIV Seropositivity/genetics*
;
HIV-1/isolation & purification*
;
Homosexuality, Male/statistics & numerical data*
;
Humans
;
Male
;
Mutation
;
Phylogeny
;
Polymerase Chain Reaction
;
Prevalence
;
RNA, Viral/genetics*
;
pol Gene Products, Human Immunodeficiency Virus/genetics*
2.Establishment and application of a high-throughput screening assay for premature activation of HIV-1 precursors.
Quan ZHANG ; Xiao-yu LI ; Zhen-long LIU ; Ping-ping JIA ; Xiao-lu WEI ; Li-xun ZHAO ; Jian-dong JIANG ; Shan CEN
Acta Pharmaceutica Sinica 2010;45(2):247-252
Strict regulation of HIV-1 PR function is critical for efficient production of mature viral particles. During viral protein expression and viral assembly, HIV-1 PR located within Gag-Pol precursor must be inactive to prevent premature cytoplasmic processing of the viral Gag and Gag-Pol precursors. Premature activation of HIV-1 precursors leads to major defects in viral assembly and production of viral particles. A cell-level premature activation of HIV-1 precursors assay using bioluminescence resonance energy transfer (BRET) was established. Three thousand compounds were screened to evaluate this assay. The results showed that the assay is sensitive, specific and stable (Z' factor is 0.905).
Anti-HIV Agents
;
pharmacology
;
Benzoxazines
;
pharmacology
;
Bioluminescence Resonance Energy Transfer Techniques
;
methods
;
Fusion Proteins, gag-pol
;
genetics
;
metabolism
;
HEK293 Cells
;
HIV Protease
;
metabolism
;
physiology
;
HIV-1
;
enzymology
;
High-Throughput Screening Assays
;
methods
;
Humans
;
Plasmids
;
genetics
;
Protein Precursors
;
metabolism
;
physiology
;
Pyridazines
;
pharmacology
;
Transfection
;
Virion
;
growth & development
;
Virus Assembly
;
gag Gene Products, Human Immunodeficiency Virus
;
genetics
;
metabolism
3.Comparison between different gene and near full-length genome on the phylogenetic analyses of HIV-1 subtype B' in China.
Zhe LI ; Yao YANG ; Jing WEI ; Yi FENG ; Hui XING ; Xiang HE ; Yi-Ming SHAO
Chinese Journal of Virology 2012;28(4):366-371
This study aims to compare the influence of different genes to the results of HIV-1 subtype B' phylogenetic analyses. We first split 47 near full-length genome sequences of subtype B' into different regions (gag, pol, vif, vpr, vpu, env, nef), which derived from various risk populations and geographic regions from Thailand, Myanmar and China from published studies. Phylogenetic analyses were performed to each region obtained. The phylogenetic results of different regions were compared to that of the near full-length genome sequences. The pol gene was found to have the lowest diversity and evolutionary rate, and could repeat the phylogenetic results by using near full-length genome sequences. Although the env gene has the highest diversity and evolutionary rate, it could not achieve the similar results. This study compared the influence to the results of HIV-1 subtype B' phylogenetic analyses by using different genes and laid foundation for further molecular survey and analyses of the transmission of subtype B' in China.
Amino Acid Sequence
;
China
;
epidemiology
;
Cluster Analysis
;
Genes, Viral
;
genetics
;
HIV-1
;
classification
;
genetics
;
Molecular Epidemiology
;
Molecular Sequence Data
;
Phylogeny
;
pol Gene Products, Human Immunodeficiency Virus
;
chemistry
;
genetics
4.Distribution of subtypes of pol gene in HIV-1 epidemic strains in Guangxi Zhuang Autonomous Region, 2010- 2012.
Hong WANG ; Bingyu LIANG ; Bo ZHOU ; Junjun JIANG ; Jiegang HUANG ; Rongfeng CHEN ; Fangning ZHAO ; Minlian WANG ; Jie LIU ; Wenwei LI ; Li YE ; Hao LIANG
Chinese Journal of Preventive Medicine 2016;50(1):79-84
OBJECTIVETo investigate the distribution and proportion of subtypes of pol gene in HIV-1 epidemic strains in Guangxi Autonomous Region.
METHODS152 HIV-1 patients were enrolled from 11 cities in Guangxi Autonomous Region from 2010 to 2012 by convenient sampling. Inclusion criterias were listed as the fdlowing: HIV-1 infection was confirmed by Western blot, HIV-1 viral load >1 000 copies/ml, > 18 year-old, and without any serious illnesses. 5 ml of peripheral blood samples were obtained from each patient. The viral RNA was isolated from plasma and used for amplification of full-length pol gene by nested RT-PCR. The amplified products were sequenced. After editing and modification, all sequences were characterized for preliminary subtyping by genotyping and confirmed with phylogenetic tree constructed by MEGA 5.03 software. The recombinant identification of 2 unknown recombinant strains was determined by RIP and jpHMM at GOBICS.
RESULTSAmong 152 patients, 137 full-length pol genes were successfully amplified and 127 HIV-1 subtypes were identified. The distribution and proportion of subtypes was summarized as the following 71 cases of CRF01_AE, accounting for 55.9% (71/127), 38 CRF08_BC, 29.9% (38/127), 13 CRF07_BC, 10.2% (13/127), and 3 B (B'), 2.4% (3/127), 2 unknown recombinant strains, 1.6% (2/127). In 11 cites of Guangxi Autonomous Region, subtype CRF01_AE was the dominant strain. Among heterosexual transmitted patients and drug abusers, the proportions of subtype CRF01_AE were 67.4% (58/86) and 34.1% (14/41), respectively. There was a significance different in the distribution of CRF01_AE in different routes of transmission (χ(2)=15.07, P<0.001). In age 21- 35, age 36- 60 and age>60 groups, the proportions of CRF01_AE was 43.6% (17/39), 57.6% (38/66), 77.3% (17/22), and CRF08_BC was 43.6% (17/39), 28.8% (19/66), 9.1% (2/22), respectively, the difference in proportions was significant(χ(2)=8.48, P= 0.014). The patterns of two unknown recombinant strains were found to be CRF01_AE/B (B') and CRF01_AE/C/B(B'), respectively.
CONCLUSIONCRF01_AE was the dominant HIV-1 subtype in Guangxi Autonomous Region from 2010 to 2012, with heterosexual transmission as its main spreading route. The two unknown recombinant strains in Guangxi Autonomous Region were reconstructed by subtype CRF01_AE and CRF_BC.
Blotting, Western ; China ; epidemiology ; Cities ; Drug Users ; Genes, pol ; Genotype ; HIV Infections ; epidemiology ; transmission ; virology ; HIV-1 ; genetics ; Humans ; Phylogeny ; Polymerase Chain Reaction ; RNA, Viral ; blood ; pol Gene Products, Human Immunodeficiency Virus ; genetics
5.Epidemiological characteristics of molecular transmission cluster among reported HIV/AIDS cases in Jiaxing city, Zhejiang province, 2017.
M Y LUO ; X H PAN ; Q FAN ; J F ZHANG ; R GE ; J JIANG ; W J CHEN
Chinese Journal of Epidemiology 2019;40(2):202-206
Objective: To understand the epidemiological characteristics of one large HIV molecular transmission cluster in Jiaxing city, Zhejiang province, 2017 in order to select those people under high-risk and providing basis for programs on prevention. Methods: During 2017, newly diagnosed HIV/AIDS cases in this city were recruited. Plasma samples were collected from subjects, followed by RNA extraction, RT-PCR and nest-PCR for pol gene amplification, before being sequenced and aligned. Mega 6.0 software was used to construct phylogenetic tree, and Cytoscape 3.6.0 software was used to identify HIV molecular transmission clusters. Cases within the large transmission clusters were investigated, using a field-epidemiology-questionnaire. Data related to socio-demographics and previous sexual behaviors were collected and EpiData 3.0 and SPSS 20.0 software were used. Results: In the large transmission cluster with subtype identified as CRF07_BC, in Jiaxing, 2017, 26 cases of the total 30 cases were investigated. A total of 80.8% (21/26) could be identified as newly infected within the last two years and 30.8%(8/26) could be identified as newly infected within the last one year, including 22 cases infected locally. Among several infected cases who were at age 45 years or older, they admitted that they had experienced unprotected sexual contacts in local city for long time and having had more than 10 disclosed sexual contacts within the last two years at the local venues. Conclusions: This molecular cluster had been formed and scaled up quickly in recent two years, it has played an important role in promoting and scaling up the HIV transmission. Three cases identificed as high risk played an importantrde role in scaling up this cluster.
Amplified Fragment Length Polymorphism Analysis
;
China/epidemiology*
;
Genes, pol
;
Genotype
;
HIV Infections/transmission*
;
HIV-1/isolation & purification*
;
Humans
;
Molecular Epidemiology
;
Phylogeny
;
Polymerase Chain Reaction
;
RNA, Viral/blood*
;
Sexual Behavior
;
pol Gene Products, Human Immunodeficiency Virus
6.Analyses on antigen epitopes and drug resistance mutations of HIV-1 gag and pol genes.
Cheng-Zhang SHANG ; Guo-Min CHEN ; Huai-Yu ZHANG ; Yi ZENG
Chinese Journal of Virology 2012;28(4):351-357
To study the CTL antigen epitopes and drug resistance mutations of HIV-1 gag and pol genes through analyzing gag and pol gene sequences. The HIV-1 gag and pol gene fragments were amplified using nested polymerase chain reaction. A total of 23 PCR sequences, 449 cloned gag sequences and 402 cloned pol sequences were obtained. Sequence analyses showed the 23 samples were subtype B or B'. A total of 4 in 8 CTL antigen epitopes appeared 8 mutations in consensus sequence of subtype B and B'. There were no mutations found in the PCR sequences, whereas a few mutations were found in clone sequences (9.80%) in 5 antigen epitopes in p24 region. Eighteen PIs-related mutations and 24 RTIs-related mutations were found in PCR sequences and clone sequences in pol gene region, in which 17 (94.44%) PIs-related mutations and 15 (62.50%) RTIs-related mutations were found only in the clone sequences, respectively. The results showed that the prevalence of HIV-1 drug resistance strains in this study was at a higher level (17.39%), suggesting that some samples were resistant.to existing antiviral drugs.
Antigens, Viral
;
immunology
;
DNA Mutational Analysis
;
Drug Resistance, Viral
;
genetics
;
Epitopes
;
immunology
;
HIV-1
;
classification
;
drug effects
;
genetics
;
immunology
;
Human Immunodeficiency Virus Proteins
;
genetics
;
Mutation
;
Phylogeny
;
T-Lymphocytes, Cytotoxic
;
immunology
;
gag Gene Products, Human Immunodeficiency Virus
;
genetics
;
pol Gene Products, Human Immunodeficiency Virus
;
genetics
7.Construction of replication-deficient recombinant adenovirus expressing gag-polDelta and gp140TM genes of human immunodeficiency virus in mice.
Ying LIU ; Lan WU ; Ke-ming ZHOU ; Xu-dong ZHANG ; Kun-sue HONG ; Yi-ming SHAO
Chinese Journal of Experimental and Clinical Virology 2004;18(2):150-153
BACKGROUNDConstruction of replication-deficient recombinant adenovirus expressing gag-pol and env genes of human immunodeficiency virus (HIV) in mice.
METHODSgag-polDelta and gp140TM genes were cloned into shuttle vector pAdTrack-CMV respectively, and then the plasmids containing gag-polDelta or gp140TM gene were cotransformed with the backbone of adenovirus into E.coli BJ5183. Transfections of the recombinants were performed to obtain recombinant adenoviruses. Its immunogenicity was evaluated by testing antibody levels of mice primed with DNA vaccines and boosted with recombinant adenoviruses.
RESULTSThe replication-deficient recombinant adenovirus could express Gp140TM, Gag P55 and P24 proteins correctly. The mice primed with DNA vaccines and boosted with recombinant adenoviruses elicited high titer of HIV-1-specific antibody compared with that inoculated with DNA vaccines only.
CONCLUSIONReplication-deficient recombinant adenovirus expressing gag-polDelta and gp140TM can elicit high titer HIV-1-specific antibodies.
AIDS Vaccines ; immunology ; Adenoviridae ; genetics ; Animals ; Female ; Fusion Proteins, gag-pol ; biosynthesis ; genetics ; Gene Products, env ; biosynthesis ; genetics ; HIV-1 ; genetics ; immunology ; Mice ; Mice, Inbred BALB C ; Recombination, Genetic ; Transfection ; Vaccines, DNA ; immunology ; env Gene Products, Human Immunodeficiency Virus
8.Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008.
Pu-rong ZHENG ; Hai XUE ; Zhi-yan XIAO ; Gang LIU
Acta Pharmaceutica Sinica 2010;45(2):154-164
HIV and AIDS remain as the crucial global health concern, therefore, research and development of novel anti-HIV-1 chemical therapeutics is still of paramount significance, which may be illuminated by cases of successful marketed drugs. Herein, we document the discovery and biological profile of new anti-HIV-1 drugs approved by FDA between 2005 and 2008 and some drug candidates are also discussed.
Acquired Immunodeficiency Syndrome
;
drug therapy
;
Anti-HIV Agents
;
chemistry
;
pharmacology
;
therapeutic use
;
HIV Fusion Inhibitors
;
chemistry
;
pharmacology
;
therapeutic use
;
HIV Infections
;
drug therapy
;
HIV Integrase Inhibitors
;
chemistry
;
pharmacology
;
therapeutic use
;
HIV Protease Inhibitors
;
chemistry
;
pharmacology
;
therapeutic use
;
HIV-1
;
drug effects
;
Humans
;
Molecular Structure
;
Reverse Transcriptase Inhibitors
;
chemistry
;
pharmacology
;
therapeutic use
9.The development of anti-HIV-1 drugs.
Acta Pharmaceutica Sinica 2010;45(2):165-176
Human immunodeficiency virus type 1 (HIV-1) is the causative agent of acquired immunodeficiency disease syndrome (AIDS). After over 26 years of efforts, there is still not a therapeutic cure or an effective vaccine against HIV/AIDS. The clinical management of HIV-1 infected people largely relies on antiretroviral therapy (ART). Although highly active antiretroviral therapy (HAART) has provided an effective way to treat AIDS patients, the huge burden of ART in developing countries, together with the increasing incidence of drug resistant viruses among treated people, calls for continuous efforts for the development of anti-HIV-1 drugs. Currently, four classes of over 30 licensed antiretrovirals (ARVs) and combination regimens of these ARVs are in use clinically including: reverse transcriptase inhibitors (RTIs) (e.g. nucleoside reverse transcriptase inhibitors, NRTIs; and non-nucleoside reverse transcriptase inhibitors, NNRTIs), protease inhibitors (PIs), integrase inhibitors and entry inhibitors (e.g. fusion inhibitors and CCR5 antagonists). Here, we intend to provide updated information of currently available antiretroviral drugs for ART to promote the development of novel anti-HIV-1 drugs.
Acquired Immunodeficiency Syndrome
;
drug therapy
;
Anti-HIV Agents
;
chemistry
;
pharmacology
;
therapeutic use
;
HIV Fusion Inhibitors
;
chemistry
;
pharmacology
;
therapeutic use
;
HIV Infections
;
drug therapy
;
HIV Integrase Inhibitors
;
chemistry
;
pharmacology
;
therapeutic use
;
HIV Protease Inhibitors
;
chemistry
;
pharmacology
;
therapeutic use
;
HIV-1
;
drug effects
;
Humans
;
Molecular Structure
;
Reverse Transcriptase Inhibitors
;
chemistry
;
pharmacology
;
therapeutic use
10.Effective components against HIV-1 replicative enzymes isolated from plants.
Zong-gen PENG ; Li-jia XU ; Wen-cai YE ; Pei-gen XIAO ; Hong-shan CHEN
Acta Pharmaceutica Sinica 2010;45(2):235-240
Plant active components characterized of many different structures and activities on multiple targets, have made them to be the important sources of inhibitors on HIV-1. For finding leading compounds with new structure against HIV-1, three key HIV-1 replicative enzymes (reverse transcriptase, protease and integrase) were used as screening models. The in vitro activities of 45 plant derived components isolated from Schisandraceae, Rutaceae and Ranunculaceae were reported. Within twelve triterpene components isolated, eight compounds were found to inhibit HIV-1 protease, in these eight active compounds, kadsuranic acid A (7) and nigranoic acid (8), inhibited both HIV-1 protease and integrase; Among fifteen lignans, meso-dihydroguaiaretic acid (15) and kadsurarin (16) were active on HIV-1 reverse transcriptase, and 4, 4-di(4-hydroxy-3-methoxyphenly)-2, 3-dimethylbutanol (13) active on HIV-1 integrase. All of the six alkaloids, seven flavones, and five others compounds were not active or only with low activities against HIV-1 replicative enzymes. Further studies of the triterpene components showing strong inhibitory activities on HIV-1 were warranted.
Alkaloids
;
chemistry
;
isolation & purification
;
pharmacology
;
Anti-HIV Agents
;
chemistry
;
isolation & purification
;
pharmacology
;
Drugs, Chinese Herbal
;
chemistry
;
isolation & purification
;
pharmacology
;
Flavones
;
chemistry
;
isolation & purification
;
pharmacology
;
Guaiacol
;
analogs & derivatives
;
chemistry
;
isolation & purification
;
pharmacology
;
HIV Integrase
;
drug effects
;
HIV Protease
;
drug effects
;
HIV Reverse Transcriptase
;
antagonists & inhibitors
;
Lignans
;
chemistry
;
isolation & purification
;
pharmacology
;
Plants, Medicinal
;
chemistry
;
Ranunculaceae
;
chemistry
;
Rutaceae
;
chemistry
;
Schisandraceae
;
chemistry
;
Triterpenes
;
chemistry
;
isolation & purification
;
pharmacology